Private reference document. This page is not listed in search engines and is provided to existing Advance Peptides customers. Please do not republish it.
GHK-Cu 50mg — Research Protocol Reference
SKU CU50 · Last reviewed 29 July 2026
Research use only. The parameters below document protocols reported in published research and supplier literature. They are not medical advice, not a prescription, and not a recommendation for human use. Advance Peptides products hold no Health Canada or FDA approval. Consult a qualified healthcare professional before acting on any of it.
Dosing Protocol
GHK-Cu 50mg is administered once daily via subcutaneous injection. Inject at a consistent time each day throughout the active cycle. Because GHK-Cu contains copper, cycling is mandatory, do not use continuously beyond 12 weeks without a rest period.
Individuals with known copper sensitivity or Wilson's disease should not use this peptide.
Recommended Dose Protocol
| Phase | Dose Per Injection | Frequency | Draw Amount |
|---|
| Weeks 1–2 (intro) | 1,000mcg (1mg) | 5 on / 2 off | 7 units |
| Weeks 3–4 | 1,500mcg (1.5mg) | 5 on / 2 off | 10.5 units |
| Weeks 5–12 (maintenance) | 2,000mcg (2mg) | 5 on / 2 off | 14 units |
| Weeks 13–20 (rest) | — rest period — | 8 weeks | — rest period — |
| Repeat as needed | 2,000mcg (2mg) | 5 on / 2 off | 14 units |
⚠️ Do not exceed 2,000mcg (14 units) per injection. GHK-Cu contains copper, which accumulates with continuous use. Cap active dosing at 12 weeks and complete the full 8-week rest period before repeating. Do not skip or shorten the rest phase. ⚠️
Cycle length: 12 weeks active, 8 weeks rest. The rest period is driven by GHK-Cu's copper content, copper accumulates with continuous use and the off period allows clearance. Do not skip or shorten the rest phase.
In biohacking forums, cycles of 8–12 weeks at 1–2mg/day are common, with a 4-week rest between cycles. These are community-derived, not clinical. Always complete the standard 12-week cycle first, and keep rest periods at least as long as the active phase.
Administration Timing
Inject once daily at a consistent time. Evening dosing aligns with the body's overnight collagen synthesis window and is preferred by most researchers.
- Evening preferred: Injecting in the evening aligns GHK-Cu activity with peak overnight collagen production and tissue repair signalling.
- Consistency over timing: The same time each day matters more than the specific hour. Choose a time sustainable for 12 weeks.
- No food restrictions: Fasted administration is not required. Inject before or after meals without affecting activity.
- Rotate injection sites: Alternate across the abdomen and outer thighs to minimise local tissue stress across a 12-week daily cycle.
- Mandatory rest: Stop at Week 12. Rest for 8 weeks before repeating. Copper clearance requires the full rest period.
Protect the reconstituted vial from light between doses, UV exposure degrades GHK-Cu.
Notes & Best Practices
- Copper accumulation, mandatory off period: GHK-Cu delivers copper into tissue. The 8-week rest period allows the body to clear it. Do not extend cycles past 12 weeks or shorten the rest.
- Micro needle for intro phase: 7 units on a standard U-100 is difficult to measure accurately. Use a 3mL micro needle syringe for Weeks 1–2, then switch to standard U-100 from Week 3.
- UV sensitivity: GHK-Cu degrades under light exposure. Store the vial wrapped in foil or in a dark refrigerator compartment. Draw doses quickly and recap promptly.
- Effects build over the cycle: Anti-inflammatory and wound-healing effects are typically noticeable within 2–4 weeks. Collagen and skin remodelling changes compound from Week 6 onward and continue after the cycle ends.
- Discard at 30 days post-reconstitution: Do not use beyond 30 days regardless of remaining volume.
High Dosage Side Effects
Taking too much GHK-Cu can increase side effects. Signs your dose may be too high:
- Injection site redness or irritation: GHK-Cu is generally well-tolerated at the injection site, but persistent redness beyond 24 hours suggests local overload. Reduce dose and rotate sites.
- Metallic taste or copper-like sensation: A persistent metallic taste can indicate elevated copper levels. Reduce dose and extend the rest period before the next cycle.
- Headache or mild nausea: Reduce dose and hold for 3–5 days before reassessing. These typically resolve as the body adjusts.
- Fatigue or lethargy: Step back to the previous dose level and hold for one week before increasing again.
If symptoms persist after dose reduction, pause the cycle and consult a healthcare professional before continuing.
Low Dosage Side Effects
A dose may be too low if expected effects are absent after consistent use. Common indicators:
- No skin firmness or texture improvement after 6–8 weeks: Collagen remodelling takes time, assess at the end of the full 12-week cycle, not mid-cycle.
- No reduction in fine lines or improved elasticity after 8–10 weeks: Confirm injection technique before adjusting dose. Intradermal placement near target areas improves local uptake.
- No wound healing improvement after 3–4 weeks: If healing response is absent, confirm dose accuracy using the draw reference and verify reconstitution concentration.
If well-tolerated after a full 12-week cycle with no response, take the full rest period and reassess on the next cycle before considering a dose adjustment.
⚠️ This is for informational purposes only. For medical advice or diagnosis, consult a professional. ⚠️